Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Patient Safety Competency-Building Program for Healthcare Professionals in Pediatric Cardiac Critical Care in Ethiopia

28 de septiembre de 2026 actualizado por: Woong-Han Kim

Development and Evaluation of a Patient Safety Competency-Building Program for Healthcare Professionals in Pediatric Cardiac Critical Care in Ethiopia

This study aims to develop and evaluate a patient safety competency-building program for healthcare professionals involved in pediatric cardiac critical care in Ethiopia. The program consists of educational modules addressing key areas of patient safety and is delivered in person at a tertiary hospital in Addis Ababa, Ethiopia. Patient safety competence is assessed before and immediately after each training round, and acceptability, appropriateness, and feasibility are assessed immediately after each training round as implementation outcomes.

Descripción general del estudio

Estado

Activo, no reclutando

Condiciones

Intervención / Tratamiento

Descripción detallada

The patient safety competency-building program comprises nine educational modules delivered across three training rounds, with selected modules provided during each round. Healthcare professionals involved in pediatric cardiac critical care may participate in one or more training rounds, and participants may therefore differ across rounds. For each training round, patient safety competence is assessed before the training and immediately after its completion as a common educational outcome. Medication safety competence is assessed before and immediately after the first training round as a round-specific educational outcome. Acceptability, appropriateness, and feasibility are assessed immediately after each training round as implementation outcomes.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

41

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Addis Ababa
      • Addis Ababa, Addis Ababa, Etiopía
        • Tikur Anbessa Specialized Hospital

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Healthcare professionals involved in pediatric cardiac critical care at Tikur Anbessa Specialized Hospital, including physicians, nurses, perfusionists, and other relevant healthcare professionals
  • Able to understand the purpose and procedures of the study and voluntarily provide informed consent

Exclusion Criteria:

  • Healthcare professionals who are on leave or are not directly involved in pediatric cardiac critical care at the time of the study
  • Individuals who are unable to adequately understand or participate in the educational program conducted in English, even with Amharic language support

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Investigación de servicios de salud
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Patient Safety Competency-Building Program

Participants receive a patient safety competency-building program designed for healthcare professionals involved in pediatric cardiac critical care. The program comprises nine educational modules and is delivered in person across three training rounds, with selected patient safety modules provided during each round.

The patient safety competency-building program consists of nine educational modules: Patient Safety Principles; Teamwork and Communication; Surgical Safety; Medication Safety; Blood Transfusion Safety; Infection Control; Patient Assessment and Clinical Decision-Making; Safety Equipment Management; and Patient Safety Incident Response and Reporting. Selected modules are delivered during each training round through in-person lectures, group discussions, and practical activities.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Patient Safety Competence
Periodo de tiempo: Before and immediately after each training round

Patient safety competence is measured using the Health Professional Education in Patient Safety Survey (H-PEPSS), a 16-item self-report instrument covering six domains: working in teams with other health professionals, communicating effectively, managing safety risks, understanding human and environmental factors, recognizing and responding to adverse events, and culture of safety. Scores are calculated as the mean of the 16 items, with possible scores ranging from 1 to 5; higher scores indicate greater perceived patient safety competence.

Before and immediately after each training round

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Medication Safety Competence
Periodo de tiempo: Before and immediately after the first training round

Medication safety competence is measured using the Medication Safety Competence Scale (MSCS), a 36-item self-report instrument covering six domains: patient-centered medication management, improvement of safety problems, management of effecting factors, safety risk management, multidisciplinary collaboration, and responsibility in the nursing profession. Scores are calculated as the mean of the 36 items, with possible scores ranging from 1 to 5; higher scores indicate greater medication safety competence.

Before and immediately after the first training round

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Acceptability of the Intervention
Periodo de tiempo: Immediately after each training round

Acceptability is measured using the Acceptability of Intervention Measure (AIM). The AIM consists of four items rated on a 5-point Likert scale. Scores are calculated as the mean of the four items, ranging from 1 to 5; higher scores indicate greater acceptability of the intervention.

Immediately after each training round
Appropriateness of the Intervention
Periodo de tiempo: Immediately after each training round

Appropriateness is measured using the Intervention Appropriateness Measure (IAM). The IAM consists of four items rated on a 5-point Likert scale. Scores are calculated as the mean of the four items, ranging from 1 to 5; higher scores indicate greater perceived appropriateness of the intervention.

Immediately after each training round
Feasibility of the Intervention
Periodo de tiempo: Immediately after each training round

Feasibility is measured using the Feasibility of Intervention Measure (FIM). The FIM consists of four items rated on a 5-point Likert scale. Scores are calculated as the mean of the four items, ranging from 1 to 5; higher scores indicate greater perceived feasibility of the intervention.

Immediately after each training round
Program Satisfaction
Periodo de tiempo: Immediately after each training round

Program satisfaction is assessed using a questionnaire developed by the research team. The questionnaire includes 5-point ratings of overall satisfaction, individual educational sessions, and five aspects of the educational experience, as well as a 10-point rating of achievement of the program objectives. Higher scores indicate more favorable evaluations. Open-ended questions are included to obtain additional participant feedback.

Immediately after each training round

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Woong-Han Kim, MD, PhD, Seoul National University Hospital

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

7 de agosto de 2026

Finalización primaria (Estimado)

1 de diciembre de 2027

Finalización del estudio (Estimado)

1 de diciembre de 2027

Fechas de registro del estudio

Enviado por primera vez

21 de septiembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

21 de septiembre de 2026

Publicado por primera vez (Actual)

28 de septiembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

1 de octubre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

28 de septiembre de 2026

Última verificación

1 de agosto de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • H-2607-045-1764

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .